Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
King Legacy is recalling Levoxyl tablets because they were below specification for potency at the expiry stability point.
Lloyd Inc. of Iowa is recalling Levothroid (levothyroxine sodium) tablets due to cGMP deviations and insufficient stability data.
King Legacy is recalling Levoxyl tablets because they were below specification for potency at the expiry stability point.
Lloyd Inc. of Iowa is recalling Levothroid (levothyroxine sodium) tablets due to cGMP deviations and insufficient stability data.
Lloyd Inc. of Iowa is recalling 3.8 million Thyro-Tab tablets due to cGMP deviations and insufficient stability data.
Lloyd Inc. of Iowa is recalling bulk Thyro-Tab tablets due to cGMP deviations and stability failures. The product was repackaged and distributed nationwide.
Mylan Institutional, Inc. is recalling 1,621 boxes of Budesonide Capsules, 3 mg, because routine stability testing showed out-of-specification dissolution results.
Aaron Industries is recalling Rite Aid brand Tussin Cough & Cold Mucus Relief CF due to the presence of white precipitate, identified as the active ingredient guaifenesin.
Novartis Consumer Health is recalling 3,828 tubes of Lamisil AT antifungal cream because the lot and expiration dates may be illegible.
Green Valley Drugs is recalling Cyanocobalamin 1000 mcg/mL injection because testing revealed positive sterility results.
Performance Plus Marketing is recalling BLUE Diamond Platinum Capsules because they may contain undeclared sildenafil, tadalafil, and analogues, making them unapproved drugs.
Performance Plus Marketing is recalling Mojo Nights Capsules because they may contain undeclared sildenafil, tadalafil, and analogues, making them unapproved drugs.
Evol Nutrition is recalling Mojo Nights for Her capsules because they contain unapproved ingredients used to treat male erectile dysfunction.
Performance Plus Marketing, Inc. is recalling Blue Diamond Pill male sexual enhancement products because they may contain undeclared sildenafil, tadalafil, and analogues.
Consumer Concepts is recalling ROCK-IT MAN capsules because FDA analysis found they contain an unapproved sildenafil analogue.
Performance Plus Marketing is recalling Casanova Capsules because they may contain undeclared sildenafil and tadalafil, making them unapproved drugs.
Green Valley Drugs is recalling Methylprednisolone Preservative Free 40 mg/mL injectable suspension because testing revealed positive sterility results.
Green Valley Drugs is recalling 529 vials of Magnesium Sulfate Injection because the pharmacy could not ensure the products were sterile.
Green Valley Drugs is recalling Lipotropic With Vitamins, Carnitine, Chromium and Glutamine Injection because the pharmacy could not ensure the products were sterile.
Green Valley Drugs is recalling Modified Myers Cocktail Injection vials because the pharmacy could not ensure the products were sterile.
Green Valley Drugs is recalling Estradiol Cypionate Injection because the pharmacy could not ensure the products were sterile. The recall covers all strengths and presentations distributed nationwide.
Green Valley Drugs is recalling L-Lysine Injection vials because the pharmacy could not ensure the products were sterile.
Performance Plus Marketing, Inc. is recalling Libigrow capsules marketed without FDA approval. The product may contain undeclared sildenafil, tadalafil, and analogues.
Green Valley Drugs is recalling 1,140 vials of Gentamicin Injection nationwide due to a lack of assurance of sterility in its compounding and quality control processes.
Green Valley Drugs is recalling L-Carnitine Injection nationwide due to a lack of assurance of sterility in its compounding and quality control processes.